Clinical Trial Update: A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With Semaglutide [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of ASC47 in combination with semaglutide for chronic weight management has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• ASC47
• semaglutide (semaglutide)

Snippet

Sponsor: Ascletis Pharma (China) Co., Limited | Conditions: Chronic Weight Management | Phase 1 | Status: COMPLETED